Vanda Pharmaceuticals (VNDA) Tops Q1 EPS by 1c, Revenues Beat; Offers FY20 Revenue Mid-Point Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. SPY
3. GLOB
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DGNX

Go back to Vanda Pharmaceuticals (VNDA) Tops Q1 EPS by 1c, Revenues Beat; Offers FY20 Revenue Mid-Point Guidance Above Consensus
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Delayed: 5.22 +0.19 (3.78%)
Previous Close $5.03    52 Week High $18.00 
Open $5.04    52 Week Low $6.91 
Day High $5.28    P/E N/A 
Day Low $4.96    EPS $-0.67 
Volume 964,867